Loading...
XNYS
ARE
Market cap9.82bUSD
Sep 17, Last price  
56.34USD
1D
5.27%
1Q
10.41%
Jan 2017
-49.30%
Name

Alexandria Real Estate Equities Inc

Chart & performance

D1W1MN
XNYS:ARE chart
P/E
P/S
3.31
EPS
Div yield, %
8.31%
Shrs. gr., 5y
6.14%
Rev. gr., 5y
9.42%
Revenues
2.97b
-2.59%
245,450,000316,973,000-78,791,000491,394,000487,303,000510,036,000586,073,000631,151,000726,877,000819,554,000897,893,0001,124,511,0001,327,459,0001,516,864,0001,893,785,0002,108,249,0002,576,040,0002,842,456,0003,049,706,0002,970,717,000
Net income
-1.43b
L
73,416,00093,724,000116,298,000134,601,000135,293,000131,418,000102,126,000136,217,000101,574,000144,217,000-65,901,000169,093,000517,346,000363,165,000770,959,000571,247,000521,660,000103,639,000322,949,000-1,430,535,000
CFO
1.41b
-6.01%
128,390,000185,382,000232,709,000205,950,000219,346,000246,960,000305,533,000312,727,000334,325,000342,611,000392,501,000450,325,000570,339,000683,857,000882,510,0001,010,197,0001,294,321,0001,630,550,0001,504,524,0001,414,046,000
Dividend
Sep 30, 20260.72 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500® real estate investment trust, stands as the pioneering and most seasoned entity in the specialized domain of urban office properties. Since its inception in 1994, Alexandria has uniquely focused on the ownership, operation, and development of integrated campuses tailored for the life science, technology, and agtech sectors, strategically positioned within premier innovation ecosystems. By December 31, 2020, the company commanded a market capitalization of $31.9 billion and managed an extensive North American asset portfolio totaling 49.7 million square feet. This substantial base encompasses 31.9 million RSF of operational properties, 3.3 million RSF of premium Class A spaces currently under construction, 7.1 million RSF designated for near-to-mid-term development and refurbishment, and an additional 7.4 million SF earmarked for future projects. Alexandria has cultivated a significant footprint across vital innovation hubs such as Greater Boston, San Francisco, New York City, San Diego, Seattle, Maryland, and Research Triangle. Its established expertise lies in crafting superior Class A facilities within these urban campuses, fostering dynamic and collaborative environments. These spaces are instrumental in empowering innovative tenants to successfully attract and retain world-class professionals, thereby stimulating productivity, efficiency, creativity, and overall achievement. Furthermore, Alexandria extends its support to transformative life science, technology, and agtech companies through its dedicated venture capital platform. This distinct business model, coupled with rigorous underwriting practices, ensures a diverse and high-caliber tenant roster, ultimately driving elevated occupancy rates, extended lease durations, robust rental revenues, superior financial returns, and enhanced long-term asset appreciation.

Related entities

Subsidiaries (3)
Alexandria Venture Investments, LLC
Alexandria Equities No. 7, LLC
ARE-MA Region No. 45, LLC

Key people

Thomas J. Andrews
Co-President, Regional Market Director � Greater Boston · since 2018
Dean Akio Shigenaga
Co-President, Chief Financial Officer · since 2018
Peter M. Moglia
Co-Chief Executive Officer and Co-Chief Investment Officer · since 2018
Stephen A. Richardson
Co-Chief Executive Officer · since 2018
Jennifer J. Banks
Co-Chief Operating Officer, General Counsel, Corporate Secretary · since 2018
Lawrence J. Diamond
Co-Chief Operating Officer, Regional Market Director � Maryland · since 2018
Marc E. Binda
Executive Vice President - Finance, Treasurer · since 2019
John H. Cunningham
Executive Vice President, Regional Market Director - New York City · since 2017
Andres R. Gavinet
Chief Accounting Officer · since 2012
Daniel J. Ryan
Co-Chief Investment Officer and Regional Market Director � San Diego · since 2018
Joseph Hawkman
Chief Strategic Transactions Officer · since 2019
Executive Chairman of the Board · since 2018
James H. Richardson
Director · since 2009
John L. Atkins
Independent Director · since 2007
James P. Cain
Independent Director · since 2015
Lead Independent Director · since 2016
Richard Hunter Klein
Independent Director · since 2003
Michael A. Woronoff
Independent Director · since 2017
IPO date
May 28, 1997
Employees
593
Domiciled in
US
Incorporated in
US
Legal address
C/O CSC-LAWYERS INCORPORATING SERVICE COMPANY
7 ST. PAUL STREET
SUITE 820
BALTIMORE, MD 21202
US
Headquarters
7 ST. PAUL STREET
SUITE 820
BALTIMORE, MD 21202
US
Previous name
Health Science Properties, Inc.

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT